Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings
- PMID: 3277244
- DOI: 10.1148/radiology.166.3.3277244
Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings
Abstract
A prospective clinical study of 17 patients with a histologic diagnosis of colorectal carcinoma proved at colonoscopy and surgery was performed with indium-111 anticarcinoembryonic-antigen (CEA) monoclonal antibody (MoAb), ZCE-025. MoAb scanning depicted nine of 16 primary colorectal carcinomas on planar scintigrams (true-positive findings = 56%) and ten of 16 lesions on single-photon emission computed tomography (SPECT) scans (true-positive findings = 62%). Liver metastases were detected in three of three patients, and lymph node metastases were detected in one of four patients. Immunohistochemical examination for CEA in resected colorectal cancer tissues demonstrated a positive correlation between MoAb imaging of primary lesions and cytoplasmic-stromal intracellular CEA distribution. There was no correlation between CEA serum levels and lesion detectability with MoAb scanning.
Similar articles
-
Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.J Clin Oncol. 1990 Jul;8(7):1246-54. doi: 10.1200/JCO.1990.8.7.1246. J Clin Oncol. 1990. PMID: 2193120
-
Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.Cancer. 1993 Jun 15;71(12 Suppl):4293-7. doi: 10.1002/1097-0142(19930615)71:12+<4293::aid-cncr2820711818>3.0.co;2-r. Cancer. 1993. PMID: 8389662 Clinical Trial.
-
Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.Radiology. 1987 Sep;164(3):617-21. doi: 10.1148/radiology.164.3.3303117. Radiology. 1987. PMID: 3303117 Clinical Trial.
-
[Possibilities of using monoclonal antibodies to CEA in scintigraphic diagnosis of tumors].Arch Geschwulstforsch. 1985;55(3):207-14. Arch Geschwulstforsch. 1985. PMID: 3896190 Review. German.
-
Use of monoclonal antibodies in colorectal cancer: a review.World J Surg. 1996 Feb;20(2):238-40. doi: 10.1007/s002689900037. World J Surg. 1996. PMID: 8661824 Review.
Cited by
-
Detection of colorectal carcinomas by intraoperative RIS in addition to preoperative RIS: surgical and immunohistochemical findings.Eur J Nucl Med. 1992;19(2):102-9. doi: 10.1007/BF00184124. Eur J Nucl Med. 1992. PMID: 1314182
-
Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.Eur J Nucl Med. 1989;15(6):302-6. doi: 10.1007/BF00435470. Eur J Nucl Med. 1989. PMID: 2670570
-
Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.In Vitro Cell Dev Biol. 1991 Dec;27A(12):900-6. doi: 10.1007/BF02631115. In Vitro Cell Dev Biol. 1991. PMID: 1757394
-
Relative positions of some epitopes on carcinoembryonic antigen.Cancer Immunol Immunother. 1989;30(2):92-6. doi: 10.1007/BF01665959. Cancer Immunol Immunother. 1989. PMID: 2480845 Free PMC article.
-
Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.Clin Pharmacokinet. 1995 Feb;28(2):126-42. doi: 10.2165/00003088-199528020-00004. Clin Pharmacokinet. 1995. PMID: 7736688 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources